Mednet Logo
HomeGynecologic OncologyQuestion

When is it too late to start PARP manitenance after adjuvant chemotherapy in BRCA mutated ovarian cancer who had a delay in completing genetic testing?

1 Answers
Mednet Member
Mednet Member
Gynecologic Oncology · Cooper Medical School of Rowan University

Niraparib's prescribing information specifies that in the first-line maintenance setting, patients should start treatment no later than 12 weeks after their most recent platinum-containing regimen. In the setting of maintenance after recurrent ovarian cancer, treatment should start no later than 8 w...

Register or Sign In to see full answer

When is it too late to start PARP manitenance after adjuvant chemotherapy in BRCA mutated ovarian cancer who had a delay in completing genetic testing? | Mednet